Maryline Kerlin
About Maryline Kerlin
Maryline Kerlin is a Research Scientist at Lawrence Livermore National Laboratory, specializing in radiochemistry and radio-pharmaceutical development. She holds a Ph.D. in Radiochemistry from the University of Nevada, Las Vegas, and has extensive experience in both academic and industry settings.
Work at Lawrence Livermore National Laboratory
Maryline Kerlin has been employed at Lawrence Livermore National Laboratory as a Research Scientist since 2021. In this role, she contributes to various projects that involve the development of innovative solutions to technical challenges in radio-pharmaceutical chelation. Her work is integral to advancing the laboratory's research objectives in the field of radiochemistry.
Education and Expertise
Maryline Kerlin holds a Ph.D. in Radiochemistry from the University of Nevada, Las Vegas, which she completed from 2010 to 2014. She also earned a Master of Science in Chemistry from the Institut national des Sciences appliquées de Rouen, studying from 2003 to 2008. Additionally, she completed a year of study in Nuclear Fuel Cycle and Radiochemistry at Ecole nationale supérieure de Chimie de Paris in 2007-2008. Her educational background provides a strong foundation for her expertise in radiochemical separation, organometallic synthesis, and metal production.
Background
Maryline Kerlin's professional journey includes significant experience in both academic and industrial settings. She began her career with an internship at AREVA NC La Hague in 2006. She then progressed through various roles at the University of Nevada, Las Vegas, including a Graduate Student in the Radiochemistry PhD program and a Research Intern. Her postdoctoral work includes positions at Los Alamos National Laboratory and the University of Washington, where she focused on radiochemistry and its applications.
Achievements
Throughout her career, Maryline Kerlin has made contributions to the field of radiochemistry, particularly in the development of radio-pharmaceutical anti-cancer agents. Her research emphasizes the use of synchrotron spectroscopy, radiochemistry, and inorganic chemistry. She has gained professional experience working with technetium and actinium chemistry, showcasing her ability to address complex technical problems in the field.